Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV(+) PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study

INTRODUCTION: Following hematopoietic stem cell transplantation or solid organ transplantation, patients are at risk of developing Epstein–Barr virus-positive post-transplant lymphoproliferative disease (EBV(+) PTLD), which is an ultra-rare and potentially lethal hematologic malignancy. Common treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaganti, Sridhar, Barlev, Arie, Caillard, Sophie, Choquet, Sylvain, Cwynarski, Kate, Friedetzky, Anke, González-Barca, Eva, Sadetsky, Natalia, Schneeberger, Stefan, Thirumalai, Dhanalakshmi, Zinzani, Pier L., Trappe, Ralf U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988727/
https://www.ncbi.nlm.nih.gov/pubmed/36681739
http://dx.doi.org/10.1007/s12325-022-02383-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988727/
https://www.ncbi.nlm.nih.gov/pubmed/36681739
http://dx.doi.org/10.1007/s12325-022-02383-z

Ejemplares similares